Atherosclerosis
- PMID: 31420554
- DOI: 10.1038/s41572-019-0106-z
Atherosclerosis
Abstract
Atherosclerosis, the formation of fibrofatty lesions in the artery wall, causes much morbidity and mortality worldwide, including most myocardial infarctions and many strokes, as well as disabling peripheral artery disease. Development of atherosclerotic lesions probably requires low-density lipoprotein, a particle that carries cholesterol through the blood. Other risk factors for atherosclerosis and its thrombotic complications include hypertension, cigarette smoking and diabetes mellitus. Increasing evidence also points to a role of the immune system, as emerging risk factors include inflammation and clonal haematopoiesis. Studies of the cell and molecular biology of atherogenesis have provided considerable insight into the mechanisms that link all these risk factors to atheroma development and the clinical manifestations of this disease. An array of diagnostic techniques, both invasive (such as selective coronary arteriography) and noninvasive (such as blood biomarkers, stress testing, CT and nuclear scanning), permit assessment of cardiovascular disease risk and targeting of therapies. An expanding armamentarium of therapies that can modify risk factors and confer clinical benefit is available; however, we face considerable challenge in providing equitable access to these treatments and in maximizing adherence. Yet, the clinical application of the fruits of research has advanced preventive strategies, enhanced clinical outcomes in affected individuals, and improved their quality of life. Rapidly accelerating knowledge and continued research promise to provide further progress in combating this common chronic disease.
Similar articles
-
Peripheral Arterial Disease – Diagnosis and Treatment: A Systematic Review [Internet].Stockholm: Swedish Council on Health Technology Assessment (SBU); 2008 Nov. SBU Yellow Report No. 187. Stockholm: Swedish Council on Health Technology Assessment (SBU); 2008 Nov. SBU Yellow Report No. 187. PMID: 28876730 Free Books & Documents. Review.
-
2017 Taiwan lipid guidelines for high risk patients.J Formos Med Assoc. 2017 Apr;116(4):217-248. doi: 10.1016/j.jfma.2016.11.013. Epub 2017 Feb 24. J Formos Med Assoc. 2017. PMID: 28242176 Review.
-
Clinical implications of carotid artery intima media thickness assessment on cardiovascular risk stratification in hyperlipidemic Korean adults with diabetes: the ALTO study.BMC Cardiovasc Disord. 2015 Oct 6;15:114. doi: 10.1186/s12872-015-0109-y. BMC Cardiovasc Disord. 2015. PMID: 26438201 Free PMC article.
-
Optimal risk factor modification and medical management of the patient with peripheral arterial disease.Catheter Cardiovasc Interv. 2008 Mar 1;71(4):475-89. doi: 10.1002/ccd.21401. Catheter Cardiovasc Interv. 2008. PMID: 18307227 Review.
-
Risk factors, endothelial cell turnover and lipid transport in atherogenesis.Zhonghua Yi Xue Za Zhi (Taipei). 1996 Nov;58(5):309-16. Zhonghua Yi Xue Za Zhi (Taipei). 1996. PMID: 9037845 Review.
Cited by
-
Corilagin alleviates atherosclerosis by inhibiting NLRP3 inflammasome activation via the Olfr2 signaling pathway in vitro and in vivo.Front Immunol. 2024 May 13;15:1364161. doi: 10.3389/fimmu.2024.1364161. eCollection 2024. Front Immunol. 2024. PMID: 38803504 Free PMC article.
-
Targeting leukotriene biosynthesis to prevent atherosclerotic cardiovascular disease.Cond Med. 2023 Apr;6(2):33-41. Cond Med. 2023. PMID: 38800614 Free PMC article.
-
Sonodynamic therapy for the treatment of atherosclerosis.J Pharm Anal. 2024 May;14(5):100909. doi: 10.1016/j.jpha.2023.11.016. Epub 2023 Nov 29. J Pharm Anal. 2024. PMID: 38799235 Free PMC article. Review.
-
Broader Perspective on Atherosclerosis-Selected Risk Factors, Biomarkers, and Therapeutic Approach.Int J Mol Sci. 2024 May 10;25(10):5212. doi: 10.3390/ijms25105212. Int J Mol Sci. 2024. PMID: 38791250 Free PMC article. Review.
-
The Antioxidant Dendrobium officinale Polysaccharide Modulates Host Metabolism and Gut Microbiota to Alleviate High-Fat Diet-Induced Atherosclerosis in ApoE-/- Mice.Antioxidants (Basel). 2024 May 13;13(5):599. doi: 10.3390/antiox13050599. Antioxidants (Basel). 2024. PMID: 38790704 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical